Singhe Hospitals PLC

Singhe Hospitals maintains a conservative capital structure with a debt-to-equity ratio of 0.26, below the industry median of 0.45, and a current ratio of 1.15, indicating moderate liquidity risk. Free cash flow of LKR 102.8 million supports operational flexibility, though negative net cash after debt subtraction raises near-term liquidity concerns. Profitability metrics show a return on equity of 12.73% and return on assets of 7.77%, outperforming the industry median ROE of 9.2% and ROA of 5.8%. Operating margin of 12.4% (LKR 186.5 million operating income on LKR 1.5 billion revenue) reflects efficient cost management in a price-sensitive market. Revenue is concentrated in domestic healthcare services, with no disclosed international operations. The company operates 12 laboratories and 60+ sample collection centers, suggesting geographic diversification within Sri Lanka, though no segment-specific revenue breakdown is provided. Outlook indicates flat revenue growth, with FY2024 revenue of LKR 1.5 billion and no material change projected for FY2025. Capital expenditure of LKR -99.7 million suggests asset optimization rather than expansion, consistent with a mature market position. Risk assessment flags liquidity as medium, with negative net cash after debt subtraction. Dilution risk is low, supported by no recent share issuance and no shelf registration disclosed. Adjustments in custom valuations reflect conservative debt assumptions. Recent filings show no material litigation or regulatory actions. The 2023 annual report highlights investments in diagnostic equipment and expansion of sample collection centers, though no new market entry or product launch is disclosed.